Fig. 5
From: Predicting diabetic kidney disease with serum metabolomics and gut microbiota
Faecal microbiome variations in NCs, patients with DM and DKD. (A)Alpha diversity; (B)Principal coordinates analysis (PCoA) based on Bray Curtis; (C)Non-metric multidimensional scaling (NMDS) analysis analysis based on Weighted Unifrac; (D)Composition and relative abundance of three groups at the bacterial phylum level; (E)Composition and relative abundance of three groups at the bacterial genus level. ***P < 0.001, ** P < 0.01,* P < 0.05.
